Cardiac Allograft Rejection Factor Accelerates Murine T Cell-Mediated Donor Deficiency of Decay-Accelerating Medof and
暂无分享,去创建一个
P. Heeger | Shuguang Yuan | W. Kwan | P. Lalli | M. Medof | V. Pavlov | H. Raedler | S. Leisman
[1] P. Heeger,et al. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis. , 2008, Blood.
[2] V. Tuohy,et al. IFN-γ and IL-17 Production in Experimental Autoimmune Encephalomyelitis Depends on Local APC–T Cell Complement Production1 , 2008, The Journal of Immunology.
[3] G. Dubyak,et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. , 2008, Immunity.
[4] P. Heeger,et al. Decay Accelerating Factor Can Control T Cell Differentiation into IFN-γ-Producing Effector Cells via Regulating Local C5a-Induced IL-12 Production1 , 2007, The Journal of Immunology.
[5] Hao Wang,et al. Inhibition of Terminal Complement Components in Presensitized Transplant Recipients Prevents Antibody-Mediated Rejection Leading to Long-Term Graft Survival and Accommodation1 , 2007, The Journal of Immunology.
[6] C. Fang,et al. Complement-Dependent Enhancement of CD8+ T Cell Immunity to Lymphocytic Choriomeningitis Virus Infection in Decay-Accelerating Factor-Deficient Mice1 , 2007, The Journal of Immunology.
[7] Devin R. Lindsey,et al. Mycobacteria‐primed macrophages and dendritic cells induce an up‐regulation of complement C5a anaphylatoxin receptor (CD88) in CD3+ murine T cells , 2007, Journal of leukocyte biology.
[8] R. Smith,et al. Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. , 2006, Journal of the American Society of Nephrology : JASN.
[9] Wuding Zhou,et al. Macrophages from C3-deficient mice have impaired potency to stimulate alloreactive T cells. , 2006, Blood.
[10] Wuding Zhou,et al. Dendritic Cell Synthesis of C3 Is Required for Full T Cell Activation and Development of a Th1 Phenotype1 , 2006, The Journal of Immunology.
[11] Wuding Zhou,et al. Local Extravascular Pool of C3 Is a Determinant of Postischemic Acute Renal Failure , 2022 .
[12] A. Valujskikh,et al. Lymphoid Sequestration of Alloreactive Memory CD4 T Cells Promotes Cardiac Allograft Survival1 , 2006, The Journal of Immunology.
[13] M. Sykes,et al. Decay-Accelerating Factor Prevents Acute Humoral Rejection Induced by Low Levels of Anti-αGal Natural Antibodies , 2006, Transplantation.
[14] A. Valujskikh,et al. Decay-accelerating factor modulates induction of T cell immunity , 2005, The Journal of experimental medicine.
[15] Hao Wang,et al. Prevention of Acute Vascular Rejection by a Functionally Blocking Anti-C5 Monoclonal Antibody Combined with Cyclosporine , 2005, Transplantation.
[16] J. Lambris,et al. The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo , 2005, The Journal of experimental medicine.
[17] H. Schuurman,et al. Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation. , 2004, Transplantation.
[18] A. Valujskikh,et al. In Vivo Helper Functions of Alloreactive Memory CD4+ T Cells Remain Intact Despite Donor-Specific Transfusion and Anti-CD40 Ligand Therapy1 , 2004, The Journal of Immunology.
[19] A. Valujskikh,et al. Antigen location contributes to the pathological features of a transplanted heart graft. , 2004, The American journal of pathology.
[20] M. Nangaku,et al. Critical Protection from Renal Ischemia Reperfusion Injury by CD55 and CD591 , 2004, The Journal of Immunology.
[21] S. Schenk,et al. Effects of T Cell Frequency and Graft Size on Transplant Outcome in Mice 1 , 2004, The Journal of Immunology.
[22] John D Lambris,et al. Complement Component 3 Is Required for Optimal Expansion of CD8 T Cells During a Systemic Viral Infection1 , 2003, The Journal of Immunology.
[23] O. Lantz,et al. Cross-primed CD8+ T cells mediate graft rejection via a distinct effector pathway , 2002, Nature Immunology.
[24] S. Sacks,et al. Local synthesis of complement component C3 regulates acute renal transplant rejection , 2002, Nature Medicine.
[25] C. Harris,et al. Tissue distribution of products of the mouse decay‐accelerating factor (DAF) genes. Exploitation of a Daf1 knock‐out mouse and site‐specific monoclonal antibodies , 2001, Immunology.
[26] A. Valujskikh,et al. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen. , 1999, Transplantation.
[27] A. Valujskikh,et al. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. , 1999, Journal of immunology.
[28] A. Valujskikh,et al. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. , 1998, Journal of immunology.
[29] A. Singer,et al. Cellular Interactions Resulting in Skin‐Allograft Rejection , 1988, Annals of the New York Academy of Sciences.
[30] W. Roberts,et al. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. , 1986, Biochemistry.
[31] V. Nussenzweig,et al. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes , 1984, The Journal of experimental medicine.
[32] J. Markmann,et al. Homeostatic proliferation is a barrier to transplantation tolerance , 2004, Nature Medicine.